Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT05514444 |
Title | Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001) |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Merck Sharp & Dohme LLC |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | NLD | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
The University of Louisville, James Graham Brown Cancer Center ( Site 0100) | RECRUITING | Louisville | Kentucky | 40245 | United States | Details |
Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0201) | RECRUITING | Toronto | Ontario | M5G 2M9 | Canada | Details |
Rambam Health Care Campus-Oncology Division ( Site 0300) | RECRUITING | Haifa | 3109601 | Israel | Details | |
Hadassah Medical Center-Oncology ( Site 0302) | RECRUITING | Jerusalem | 9112001 | Israel | Details | |
Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL) ( Site 0401) | RECRUITING | Amsterdam | Noord-Holland | 1066CX | Netherlands | Details |
Amsterdam UMC, locatie VUmc ( Site 0400) | RECRUITING | Amsterdam | Noord-Holland | 1081HV | Netherlands | Details |